Who are the 15 major players in the global orthobiologics market?

The global orthobiologics market is expected to grow from $4.66 billion in 2017 to reach $8.06 billion by 2023, increasing at a 5.7 percent compound annual growth rate, according to a Market.Biz report.

Advertisement
By: Staff

The major players in the global orthobiologics market include:

1. Stryker

2. RTI Surgical

3. Bioventus

4. Zimmer Biomet

5. Seaspine

6. Kuros Biosciences

7. Globus Medical

8. Xtant Medical

9. Harvest Technologies

10. Nuvasive

11. Orthofix International

12. Arthrex

13. Medtronic

14. K2M

15. DePuy Synthes

More articles on biologics:

Tissue Regenix group inks deal, expands DermaPure access in US

Biologica Technologies to exhibit ProteiOS data at AANS Annual Meeting: 3 insights

Infuse gets new FDA indication for lateral, anterior spinal fusions with PEEK implants: 5 things to know

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in Biologics

Advertisement

Comments are closed.